Do analysts prefer ZJYL or SRTS?

Sensus Healthcare has a consensus target price of $5.83, suggesting a potential upside of 101.85%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than Jin Medical International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable earnings and valuation, ZJYL or SRTS?

Jin Medical International has higher earnings, but lower revenue than Sensus Healthcare. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 16.21 $1.19M N/A N/A Sensus Healthcare $27.48M 1.73 -$7.72M -$0.94 N/A

Do analysts rate SRTS or INGN?

Sensus Healthcare presently has a consensus price target of $5.83, indicating a potential upside of 101.85%. Given Sensus Healthcare's higher probable upside, research analysts clearly believe Sensus Healthcare is more favorable than Inogen. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sensus Healthcare 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Inogen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Is OWLT or SRTS more profitable?

Owlet has a net margin of -8.61% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Owlet's return on equity. Company Net Margins Return on Equity Return on Assets Owlet -8.61% -601.24% -15.96% Sensus Healthcare -88.45% -21.57% -19.20%

Sensus Healthcare (SRTS) Competitors

$2.97 +0.08 (+2.77%)

As of 09:52 AM Eastern

Compare

SRTS vs. STIM, FOCL, ZJYL, INGN, and OWLT

Should you buy Sensus Healthcare stock or one of its competitors? Sensus Healthcare's main competitors and comparable companies include Neuronetics (STIM), FocalTherics (FOCL), Jin Medical International (ZJYL), Inogen (INGN), and Owlet (OWLT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sensus Healthcare compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

Sensus Healthcare has lower revenue, but higher earnings than Neuronetics. Neuronetics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$149.16M	1.02	-$39M	-$0.44	N/A
Sensus Healthcare	$27.48M	1.73	-$7.72M	-$0.94	N/A

In the previous week, Neuronetics had 1 more articles in the media than Sensus Healthcare. MarketBeat recorded 2 mentions for Neuronetics and 1 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.82 beat Neuronetics' score of 1.18 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Neuronetics	Positive
Sensus Healthcare	Very Positive

Neuronetics has a beta of 1.19, meaning that its share price is 19% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

Neuronetics presently has a consensus target price of $4.67, suggesting a potential upside of 134.51%. Sensus Healthcare has a consensus target price of $5.83, suggesting a potential upside of 101.85%. Given Neuronetics' stronger consensus rating and higher probable upside, analysts plainly believe Neuronetics is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Neuronetics has a net margin of -19.62% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-19.62%	-125.11%	-22.15%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Summary

Neuronetics beats Sensus Healthcare on 8 of the 14 factors compared between the two stocks.

How does Sensus Healthcare compare to FocalTherics?

FocalTherics (NASDAQ:FOCL) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

In the previous week, FocalTherics had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 4 mentions for FocalTherics and 1 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.82 beat FocalTherics' score of 1.22 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
FocalTherics	Positive
Sensus Healthcare	Very Positive

FocalTherics currently has a consensus price target of $7.75, suggesting a potential upside of 84.52%. Sensus Healthcare has a consensus price target of $5.83, suggesting a potential upside of 101.85%. Given Sensus Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FocalTherics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

FocalTherics has a beta of -0.06, indicating that its stock price is 106% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Sensus Healthcare has lower revenue, but higher earnings than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FocalTherics	$70.53M	2.23	-$29.25M	-$1.03	N/A
Sensus Healthcare	$27.48M	1.73	-$7.72M	-$0.94	N/A

62.7% of FocalTherics shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 10.1% of FocalTherics shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

FocalTherics has a net margin of -56.26% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FocalTherics	-56.26%	-248.00%	-44.69%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Summary

Sensus Healthcare beats FocalTherics on 10 of the 16 factors compared between the two stocks.

How does Sensus Healthcare compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

In the previous week, Jin Medical International and Jin Medical International both had 1 articles in the media. Sensus Healthcare's average media sentiment score of 1.82 beat Jin Medical International's score of 1.25 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Jin Medical International	Positive
Sensus Healthcare	Very Positive

Sensus Healthcare has a consensus target price of $5.83, suggesting a potential upside of 101.85%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than Jin Medical International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Jin Medical International has a net margin of 0.00% compared to Sensus Healthcare's net margin of -88.45%. Jin Medical International's return on equity of 0.00% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Sensus Healthcare	-88.45%	-21.57%	-19.20%

Jin Medical International has a beta of 7.4, indicating that its stock price is 640% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

Jin Medical International has higher earnings, but lower revenue than Sensus Healthcare.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	16.21	$1.19M	N/A	N/A
Sensus Healthcare	$27.48M	1.73	-$7.72M	-$0.94	N/A

25.3% of Sensus Healthcare shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Sensus Healthcare beats Jin Medical International on 7 of the 13 factors compared between the two stocks.

How does Sensus Healthcare compare to Inogen?

Sensus Healthcare (NASDAQ:SRTS) and Inogen (NASDAQ:INGN) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

Inogen has a net margin of -6.94% compared to Sensus Healthcare's net margin of -88.45%. Inogen's return on equity of -13.17% beat Sensus Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Inogen	-6.94%	-13.17%	-8.36%

Sensus Healthcare has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sensus Healthcare	$27.48M	1.73	-$7.72M	-$0.94	N/A
Inogen	$348.67M	0.48	-$22.75M	-$0.90	N/A

In the previous week, Inogen had 2 more articles in the media than Sensus Healthcare. MarketBeat recorded 3 mentions for Inogen and 1 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.82 beat Inogen's score of 0.61 indicating that Sensus Healthcare is being referred to more favorably in the media.

Company	Overall Sentiment
Sensus Healthcare	Very Positive
Inogen	Positive

25.3% of Sensus Healthcare shares are held by institutional investors. Comparatively, 89.9% of Inogen shares are held by institutional investors. 10.2% of Sensus Healthcare shares are held by insiders. Comparatively, 2.5% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Sensus Healthcare has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market. Comparatively, Inogen has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market.

Sensus Healthcare presently has a consensus price target of $5.83, indicating a potential upside of 101.85%. Given Sensus Healthcare's higher probable upside, research analysts clearly believe Sensus Healthcare is more favorable than Inogen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Inogen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Inogen beats Sensus Healthcare on 9 of the 15 factors compared between the two stocks.

How does Sensus Healthcare compare to Owlet?

Owlet (NYSE:OWLT) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

72.6% of Owlet shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 10.2% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Sensus Healthcare has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Owlet	$105.70M	1.28	-$39.68M	-$0.75	N/A
Sensus Healthcare	$27.48M	1.73	-$7.72M	-$0.94	N/A

Owlet presently has a consensus target price of $15.00, indicating a potential upside of 225.03%. Sensus Healthcare has a consensus target price of $5.83, indicating a potential upside of 101.85%. Given Owlet's higher possible upside, equities analysts plainly believe Owlet is more favorable than Sensus Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Owlet	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sensus Healthcare	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Owlet has a net margin of -8.61% compared to Sensus Healthcare's net margin of -88.45%. Sensus Healthcare's return on equity of -21.57% beat Owlet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Owlet	-8.61%	-601.24%	-15.96%
Sensus Healthcare	-88.45%	-21.57%	-19.20%

In the previous week, Owlet had 2 more articles in the media than Sensus Healthcare. MarketBeat recorded 3 mentions for Owlet and 1 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 1.82 beat Owlet's score of 1.09 indicating that Sensus Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Owlet	Positive
Sensus Healthcare	Very Positive

Owlet has a beta of 1.91, suggesting that its stock price is 91% more volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market.

Summary

Owlet beats Sensus Healthcare on 9 of the 15 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SRTS vs. The Competition

Export

Metric	Sensus Healthcare	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$48.89M	$5.58B	$7.26B	$13.21B
Dividend Yield	N/A	1.75%	2.52%	22.89%
P/E Ratio	-3.16	20.86	206.66	19.94
Price / Sales	1.78	67.32	562.21	81.34
Price / Cash	N/A	32.25	77.16	53.04
Price / Book	1.01	5.86	10.75	6.03
Net Income	-$7.72M	$146.14M	$3.50B	$380.34M
7 Day Performance	1.02%	-0.96%	-2.91%	-2.34%
1 Month Performance	-5.11%	-3.60%	-7.38%	-5.31%
1 Year Performance	-7.76%	1.44%	2.96%	-2.94%

Sensus Healthcare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SRTS Sensus Healthcare	3.4853 of 5 stars	$2.97 +2.8%	$5.83 +96.4%	-10.0%	$48.89M	$27.48M	N/A	60	Positive News
STIM Neuronetics	3.5518 of 5 stars	$2.25 +2.0%	$4.67 +107.9%	-27.9%	$171.06M	$155.10M	N/A	658	Positive News
FOCL FocalTherics	4.4436 of 5 stars	$4.25 +0.5%	$7.75 +82.4%	N/A	$159.50M	$70.53M	N/A	230	Positive News
ZJYL Jin Medical International	1.275 of 5 stars	$1.98 flat	N/A	-74.1%	$155.30M	$19.73M	N/A	273	Positive News Gap Down
INGN Inogen	1.0503 of 5 stars	$5.80 -2.3%	N/A	-21.1%	$153.96M	$348.67M	N/A	753

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SRTS) was last updated on 10/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sensus Healthcare (SRTS) Competitors

SRTS vs. STIM, FOCL, ZJYL, INGN, and OWLT

How does Sensus Healthcare compare to Neuronetics?

Summary

How does Sensus Healthcare compare to FocalTherics?

Summary

How does Sensus Healthcare compare to Jin Medical International?

Summary

How does Sensus Healthcare compare to Inogen?

Summary

How does Sensus Healthcare compare to Owlet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sensus Healthcare (SRTS) Competitors

SRTS vs. STIM, FOCL, ZJYL, INGN, and OWLT

How does Sensus Healthcare compare to Neuronetics?

Which has stronger earnings & valuation, STIM or SRTS?

Does the media favor STIM or SRTS?

Which has more volatility and risk, STIM or SRTS?

Do analysts recommend STIM or SRTS?

Do insiders & institutionals hold more shares of STIM or SRTS?

Is STIM or SRTS more profitable?

Summary

How does Sensus Healthcare compare to FocalTherics?

Does the media favor FOCL or SRTS?

Do analysts rate FOCL or SRTS?

Which has more volatility and risk, FOCL or SRTS?

Which has better valuation and earnings, FOCL or SRTS?

Do insiders and institutionals hold more shares of FOCL or SRTS?

Is FOCL or SRTS more profitable?

Summary

How does Sensus Healthcare compare to Jin Medical International?

Does the media refer more to ZJYL or SRTS?

Do analysts prefer ZJYL or SRTS?

Is ZJYL or SRTS more profitable?

Which has more risk and volatility, ZJYL or SRTS?

Which has preferable earnings and valuation, ZJYL or SRTS?

Do institutionals & insiders hold more shares of ZJYL or SRTS?

Summary

How does Sensus Healthcare compare to Inogen?

Is SRTS or INGN more profitable?

Which has better earnings and valuation, SRTS or INGN?

Does the media prefer SRTS or INGN?

Do institutionals and insiders hold more shares of SRTS or INGN?

Which has more volatility & risk, SRTS or INGN?

Do analysts rate SRTS or INGN?

Summary

How does Sensus Healthcare compare to Owlet?

Do insiders and institutionals believe in OWLT or SRTS?

Which has preferable valuation & earnings, OWLT or SRTS?

Do analysts prefer OWLT or SRTS?

Is OWLT or SRTS more profitable?

Does the media prefer OWLT or SRTS?

Which has more risk & volatility, OWLT or SRTS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SRTS vs. The Competition

Sensus Healthcare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools